Arjun Surya

Arjun Surya is a prominent inventor based in New Delhi, India. He has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds for treating various diseases. With a total of three patents to his name, Surya's work focuses on innovative solutions that address critical health challenges.

Latest Patents

One of Arjun Surya's latest patents is related to small molecule modulators of the human STING protein. This invention involves compounds that can modulate the Stimulator of Interferon Genes (STING) protein, potentially offering new treatment options for diseases such as cancer and microbial infections. Another significant patent involves inhibitors of the kynurenine pathway. This application provides novel inhibitors of indoleamine 2,3-dioxygenase-1 and/or indoleamine 2,3-dioxygenase-2 and/or tryptophan 2,3-dioxygenase. These compounds are designed to treat diseases resulting from dysregulation of the kynurenine pathway by inhibiting the enzymatic activity or expression of the relevant enzymes.

Career Highlights

Arjun Surya has worked with notable companies in the pharmaceutical sector, including Curadev Pharma Pvt Ltd and Curadev Pharma Private Limited. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of his coworkers include Monali Banerjee and Sandip Middya. Their collaborative efforts have played a crucial role in advancing the research and development of innovative pharmaceutical solutions.

Conclusion

Arjun Surya's contributions to pharmaceutical research through his patents and collaborations highlight his commitment to addressing significant health issues. His innovative work continues to pave the way for new treatment options in the medical field.

This text is generated by artificial intelligence and may not be accurate.